Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
The US FDA Approves The Expanded Manufacturing Process Of ADMA Biologics…
Galera Therapeutics Inc (NASDAQ:GRTX) Reports Updated Results Of Phase 1/ 2…
Amarin Corporation Plc (NASDAQ:AMRN) Will Commercialize VAZKEPA In Q3 2021: Reports…
Akebia Therapeutics Inc (NASDAQ:AKBA) Will Post Q1 2021 Revenues On May…
Cara Therapeutics Inc (NASDAQ:CARA) Reports Topline Results Of Oral KORSUVA In…
Finance
Amarin Corporation Plc (NASDAQ:AMRN) Receives Marketing Authorization For Icosapent Ethyl From…
Hollywall Entertainment Inc (OTCMKTS:HWAL): Under-the-Radar NFT Star in the Making? (PLBY,…
GeoVax Labs (GOVX) surges on positive sentiment
Compass Pathways (CMPS) could lead psychedelic sector
Moderna Inc (NASDAQ:MRNA) Signs Deal With Baxter International Inc (NYSE:BAX) For…
Tech News
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:MGNX
Tag: NASDAQ:MGNX
MacroGenics Inc. (NASDAQ:MGNX) Reports Its Q3 Financial Results and Clinical Updates...
Ward Sport
-
November 20, 2020
0
MacroGenics Inc. (NASDAQ:MGNX) Announce Publication Of Research Supporting flotetuzumab Study in...
Kate Hudson
-
June 11, 2020
0
MacroGenics Inc. (NASDAQ:MGNX) Gives Update OnBLA Review for Margetuximab In Treating...
Kate Hudson
-
June 4, 2020
0
.td-post-views{ display: none !important; }
